Rontalizumab (Anti-IFNa1)

Rontalizumab (Anti-IFNa1) is a humanized IgG1 monoclonal antibody targets IFN-α. It can be used for the research of systemic lupus erythematosus. MW :150 KD.

Price Not Available 1mg*5 Rontalizumab (Anti-IFNa1) Supplier Page
Trivial name RhuMab IFNalpha
Catalog Number A2664
CAS# 948570-30-7
Size 1mg*5